Stefan Wawersik

Company: Q32 Bio

Job title: Vice President - Research

Seminars:

Preclinical Characterization of ADX-097, a Tissue Targeted Complement Therapeutic for Kidney Diseases 2:00 pm

Characterizing the role of local and systemic inhibition in treating kidney tissue injury Translational considerations around moving a drug from preclinical to clinical  Thoughts around biomarkers and their use within precision medicineRead more

day: Conference Day One Track A PM